Prague Med. Rep. 2021, 122, 243-256

https://doi.org/10.14712/23362936.2021.22

Therapeutic Drug Monitoring of Protein Kinase Inhibitors in Breast Cancer Patients

Jaroslava Roušarová, Martin Šíma, Ondřej Slanař

Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

Received April 1, 2021
Accepted October 20, 2021

Crossref Cited-by Linking

  • Posocco Bianca, Zanchetta Martina, Orleni Marco, Gagno Sara, Montico Marcella, Peruzzi Elena, Roncato Rossana, Gerratana Lorenzo, Corsetti Serena, Puglisi Fabio, Toffoli Giuseppe: Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method. Therapeutic Drug Monitoring 2024, 46, 485. <https://doi.org/10.1097/FTD.0000000000001174>
  • Hulin Anne, Gelé Thibaut, Fenioux Charlotte, Kempf Emmanuelle, Sahali Dil, Tournigand Christophe, Ollero Mario: Pharmacology of Tyrosine Kinase Inhibitors. CJASN 2024, 19, 927. <https://doi.org/10.2215/CJN.0000000000000395>
  • Cecchin Eleonora, Orleni Marco, Gagno Sara, Montico Marcella, Peruzzi Elena, Roncato Rossana, Gerratana Lorenzo, Corsetti Serena, Puglisi Fabio, Toffoli Giuseppe, Cecchin Erika, Posocco Bianca: Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring. IJMS 2024, 25, 10453. <https://doi.org/10.3390/ijms251910453>
  • van der Kleij Maud B. A., Guchelaar Niels A. D., Mathijssen Ron H. J., Versluis Jurjen, Huitema Alwin D. R., Koolen Stijn L. W., Steeghs Neeltje: Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology. Clin Pharmacokinet 2023, 62, 1333. <https://doi.org/10.1007/s40262-023-01293-9>
  • Burke Sarah M., Kamal Mustafa, Goey Andrew K. L.: Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human Plasma. Therapeutic Drug Monitoring 2023, 45, 327. <https://doi.org/10.1097/FTD.0000000000001063>
  • Hirabatake Masaki, Mizuno Tomoyuki, Kato Hironori, Hashida Tohru: Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer. Front. Pharmacol. 2022, 13. <https://doi.org/10.3389/fphar.2022.984002>
Crossref Cited-by Linking logo